Medtronic: Recalled Defibrillators Continue to Generate Adverse Event Reports; MAUDE Data Indicates Device Problems Persist Despite Recall

Published on Oct 13, 2023

More than a year after medical device maker Medtronic (MDT) notified customers of life-threatening defects in its implantable cardiac defibrillators—a warning that was later classified by the Food and Drug Administration as its most serious type of recall—hundreds of reports of adverse events associated with the devices continue to roll in, raising questions about whether […]

Already have an account? Log in.

This article is currently locked and only available to subscribers. Request a trial to receive unlimited access to all articles.

View Only Unlocked Articles

© 2024 the Capitol Forum